Portfolio Company · Operating Co.

AgomAb Therapeutics

Deeptech

AgomAb Therapeuticsbacked byOmnes Capital

CurrentDeeptech

Company Snapshot

AgomAb Therapeutics is a deeptech portfolio company held by Omnes Capital, with parent firm headquartered in Paris, France. Profile compiled from public sources; submit updates to extend the public record.

SectorDeeptech

Parent PE firmOmnes Capital

Ownership statusCurrent

Website—

Ownership Context

AgomAb Therapeutics is a current portfolio company of Omnes Capital, headquartered in Paris, France. Public coverage of this company is grouped under its parent firm's profile.

Sources

https://www.omnescapital.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with AgomAb Therapeutics and does not provide investment advice.